Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog click here, the HCV drug pipeline click here, and for more information on HCV clinical trials click here
Drugs in Development / Clinical Trials—Updated March 17, 2015
Monday, April 20, 2015
A 30,000-dose shipment of Olisio, the new treatment, has arrived in Egypt, and is currently undergoing tests before release on the market, the head of National Committee for the Control of Viral Hepatitis Waheed Doss told Youm 7.
Doss added that once Olisio is approved, the treatment protocol will be changed and the new drug will be used simultaneously with the currently-used American-made Sovaldi.
Saturday, April 18, 2015
Just before he took the test, Mr. Rankin said, “I think it’s important that hepatitis C testing be done without any stigma…I’m here to say as a Member of Parliament it is something that everybody should do. It is something that is a wonderful health initiative and I’m pleased to be doing it as well.”
Friday, April 17, 2015
From the community: McAuliffe Looks to Keep Hepatitis C Taskforce Working: Veteran Lawmaker Sees More Work Ahead for Productive Group
"Many times, task forces here in Springfield just don't take off or gain any traction," said McAuliffe. "In this case, the interest and productivity of this group has exceeded all expectations. We met consistently and produced a number of solid legislative recommendations which is why I feel it's important to keep it going."
The group, which first met in February of 2014, has met consistently on a bi-monthly basis and has produced a multitude legislative initiatives aimed at curbing the growing issue of Hepatitis C in our veteran and senior communities. The group has also hosted Hepatitis C Day at the State Capitol which provides informational displays and brings leading medical experts and free screenings to our State's capitol.
Good news—GNC Holding announced that it had restocked some of the herbal supplements to their stores in New York after they reached an agreement with the New York Attorney General and complied and corrected the problems. Furthermore, GNC agreed that they would adopt testing standards in the 6,000 stores nationwide that would exceed requirements that the Food and Drug Administration requires—this is a first for a major herbal supplement chain in the United States.
Additionally, GNC committed to the following best practices:
Authentication: Within 18 months GNC will implement DNA barcoding to confirm the plant's authenticity.
Broad Testing for Contaminants: GNC will test for the eight most common allergens before and after production.
Consumer transparency: GNC will prominently display signs in their stores and on their website with relevant information about the herbs and supplements including extracts, chemicals, and solvents used and explain the different processes. GNC will list all ingredients on its product labels, per existing FDA rules.
Reporting: GNC will provide semiannual reports to the Attorney General’s Office, detailing the above information.
Comment: Regarding GNC—this is excellent progress. However, where are the agreements with Target, Walmart, and Walgreens? Hopefully, the other stores will soon agree to the same terms as GNC. If you want to know the potential harm of these herbs, check out the original article—it will make you think twice before buying any herbs or supplements unless there is some type of comprehensive oversight.